Explore 3 Stock Ideas & Industry Insights Download Free Report

Merger & Acquisition(M&A)

TransDigm (NYSE:TDG) to Acquire Aerospace Alloy Maker Prince & Izant for $1.07 Billion

TransDigm Group (NYSE:TDG) announced it has entered into a definitive agreement to acquire Prince and Izant, a portfolio company of Industrial Growth Partners, for approximately 1.066 billion dollars in cash, including certain tax benefits. Headquartered in Cleveland, Ohio, Prince and Izant is a leading …

Nitish Kishor | 27 July 2026

Profusa (NASDAQ:PFSA) Signs Term Sheet to Acquire Diagnostics Firm With $111 Million in Revenue

Profusa has entered into a non-binding term sheet to acquire a privately held, commercial-stage health diagnostics and toxicology testing company, positioning the combined business to operate as a public diagnostics company with national CLIA-certified laboratories. The target company generates recurring revenue from a diversified …

Nitish Kishor | 27 July 2026

argenx (NASDAQ:ARGX) to Acquire Forte Biosciences (NASDAQ:FBRX) in $2.2 Billion Immunology Push

argenx and Forte Biosciences on Monday announced a definitive agreement under which argenx will acquire the clinical-stage biopharmaceutical company for 77 dollars per share in cash, a transaction valued at approximately 2.2 billion dollars. The deal marks a move from strategic investment to full …

Nitish Kishor | 27 July 2026

Paramount Agrees to Delay $110 Billion Warner Bros. Discovery Deal to June 2027

Paramount Skydance has agreed to delay its proposed acquisition of Warner Bros. Discovery to as late as June 2027, a multi-month delay that will ultimately raise the deal price, as the tie-up faces a legal challenge from state officials. The agreement comes after a …

Nitish Kishor | 26 July 2026

Microchip Technology (NASDAQ:MCHP) Signs Deal to Acquire Edge AI Processor Maker Hailo

Microchip Technology announced it has signed a definitive agreement to acquire Hailo, a provider of accelerated edge AI processors, advanced vision processing solutions, robotics processors, and comprehensive AI software flows. The transaction is expected to close toward the end of the current quarter ending …

Nitish Kishor | 26 July 2026

DOJ Merger Reform Could Reshape M&A Activity as Companies Reassess Deal Pipelines in H2 2026

The US merger review process has become a central factor influencing corporate deal decisions, with potential reforms at the Department of Justice (DOJ) creating renewed discussion around the future pace of mergers and acquisitions.

Vinay Lochav | 24 July 2026

Vireo Growth Inc. (OTC: VREOF) Expands Market Reach With $35M Acquisition

Vireo Growth Inc. (OTC: VREOF) has entered a $35 million purchase agreement for cannabis operations to enhance its market footprint. This strategic move could position Vireo favorably amid current market challenges, potentially driving recovery for its struggling shares.Key HighlightsVireo Growth acquires cannabis assets valued …

Vinay Lochav | 24 July 2026

Mapfre Acquires Safety Insurance (NASDAQ: SAFT) for $105 Per Share, 44% Premium

Safety Insurance Group has announced a merger agreement with Mapfre, valuing the firm at approximately $1.54 billion with cash payments of $105 per share. This move provides substantial value for investors, reflecting a premium of 44% from previous stock levels.Key HighlightsShareholders will receive $105 …

Vinay Lochav | 24 July 2026

Sleep Number's (NASDAQ: SNBRQ) Asset Sale Rises to $529.5M, Implications Loom for Investors

Sleep Number Corp has amended its asset purchase agreement, increasing the sale price from $415 million to $529.5 million, a notable 28% rise. This adjustment marks a pivotal moment for investors, as the asset sale is crucial amid the company's ongoing financial challenges.Key HighlightsThe …

Vinay Lochav | 24 July 2026

Merger With Scancell Holdings to Reshape Neuphoria's (NASDAQ: NEUP) Future

Neuphoria Therapeutics Inc. (NASDAQ: NEUP) has entered a merger agreement with Scancell Holdings plc, positioning shareholders to own approximately 11.1% of the new entity. This strategic shift highlights Neuphoria's efforts to enhance market capitalization and shareholder value amid a challenging trading environment.Key HighlightsNeuphoria Therapeutics …

Vinay Lochav | 24 July 2026
Support

Hi! How can we help you today?

Loading…